Sunridge International, Inc. (OTC BB: SNDZ.OB)   Sunridge International, Inc. recently consummated a reverse merger with Ophthalmic International to become a manufacturer and provider of fixation device that treats Open Angle and Pigmentary glaucoma. Opththalmic has developed and patented a 2-minute, non-invasive, cost effective, alternative treatment for glaucoma and ocular hypertension, known as Pneumatic Trabeculoplasty (PNT). The Company holds worldwide patents on the PNT equipment, its disposable sterile suction ring, as well as the medical procedure itself. Opthalmic having secured 2a CE marketing approval throughout Europe and Canada is currently marketing its product line through an exclusive distributor network. Opthalmic is based out of Fountain Hills, Arizona and has been in business since 1997. The Company is currently working with over seventeen global distributors serving markets in Canada, Europe, Africa and Asia. The Company is currently working with the FDA to get its approval for the sale of PNT devices in the United States. Glaucoma is the second leading cause of blindness, effecting over 70 million people worldwide. Through studies completed over the last 10 years, PNT has been proven to be a safe and effective treatment with no adverse side effects, unlike medications usually prescribed to treat glaucoma that come with a multitude of side effects. For additional information about Ophthalmic International, please visit www.oi-pnt.com   PLEASE NOTE WELL: The OTCHotline.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.OTCHotline.com/disclaimer.asp Release of Liability: Through use of this website viewing or using you agree to hold OTCHotline.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCHotline.com has been compensated by a third party twenty-two thousand shares of SNDZ for SNDZ marketing services. The third party, may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCHotline's affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice which may negatively affect the market. OTCHotline.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCHotline.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. OTCHotline.com, nor any of its affiliates are not registered investment advisors or a broker dealers.